MedTrace Logo

Use of a Modified Propofol Emulsion in Adults

NCT00690495 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-01-05

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to determine whether a modified propofol preparation shows any effect on the incidence of injection pain in adults undergoing elective surgery under general anesthesia.

Study hypothesis: The use of a modified propofol preparation will reduce the incidence of injection pain in the study group.

Conditions

  • Anesthesia

Interventions

DRUG

Propofol

Propofol (drug), intravenous, induction of anesthesia

DRUG

Propofol 1%

Propofol (drug), intravenous, induction of anesthesia

Sponsors & Collaborators

  • B. Braun Melsungen AG

    lead INDUSTRY

Principal Investigators

  • Stefan Soltész, MD, PhD · Klinik für Anästhesie und operative Intensivmedizin, Klinikum Leverkusen gGmbH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2008-09-30
Completion
2008-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00690495 on ClinicalTrials.gov